Amarin Corp Plc (AMRN)

[alm2]

Generic launch - this is all a game of chicken - the Teva case changed the equation.... generics want to make a safe sure fire profit -legal costs are a chicken feed gamble (continuing the theme) but now it’s all about assessing risk and profit for the generics
We can all pontificate about where the infringement law was / and now is .... but if you were cock sure(again continuing the theme) about making a killing profit on GV before the Teva case you are currently seriously recalculating now if you are a generic
Why risk ? For what reward ? Amarin don’t have to PR to tell the generics what they will do ... they are working it out for themselves ....
This is now a watching game ... wait see what happens ... en banc ? Further legal action to get decision changed ?? launch ..??. injunction ???... infringement/damages??

But each day as time passes by the damage shrinks just a little /and potential for Amarin to make profit in USA grows and Europe approval nears ... a slow recovery in SP over time ... hopefully ???
Alm
I